Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteriaGünter U. Höglinger, Gesine Respondek, María Stamelou et al.|Movement Disorders|2017Cited by 2.3k
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjectsPiero Parchi, Hans A. Kretzschmar, Amyn M. Rojiani et al.|Annals of Neurology|1999Cited by 1.4k
Which ante mortem clinical features predict progressive supranuclear palsy pathology?Gesine Respondek, Carolin Kurz, Thomas Arzberger et al.|Movement Disorders|2017Cited by 163
Chloroquine activates the p53 pathway and induces apoptosis in human glioma cellsE. L. Kim, Armin Giese|Neuro-Oncology|2010Cited by 151
Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trialJohannes Levin, Johannes Schwarz, Sylvia Maaß et al.|The Lancet Neurology|2019Cited by 126